- Home
- REPL vs IMXI Comparison
REPL vs IMXI Comparison
Compare REPL & IMXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REPL
- IMXI
- Stock Information
- Founded
- REPL 2015
- IMXI 1994
- Country
- REPL United States
- IMXI United States
- Employees
- REPL N/A
- IMXI N/A
- Industry
- REPL Biotechnology: Pharmaceutical Preparations
- IMXI Retail: Computer Software & Peripheral Equipment
- Sector
- REPL Health Care
- IMXI Technology
- Exchange
- REPL Nasdaq
- IMXI Nasdaq
- Market Cap
- REPL 547.0M
- IMXI 438.1M
- IPO Year
- REPL 2018
- IMXI N/A
- Fundamental
- Price
- REPL $10.07
- IMXI $14.82
- Analyst Decision
- REPL Buy
- IMXI Buy
- Analyst Count
- REPL 9
- IMXI 5
- Target Price
- REPL $10.88
- IMXI $19.60
- AVG Volume (30 Days)
- REPL 8.8M
- IMXI 456.4K
- Earning Date
- REPL 11-07-2025
- IMXI 11-11-2025
- Dividend Yield
- REPL N/A
- IMXI N/A
- EPS Growth
- REPL N/A
- IMXI N/A
- EPS
- REPL N/A
- IMXI 1.65
- Revenue
- REPL N/A
- IMXI $642,149,000.00
- Revenue This Year
- REPL N/A
- IMXI N/A
- Revenue Next Year
- REPL N/A
- IMXI $1.87
- P/E Ratio
- REPL N/A
- IMXI $9.02
- Revenue Growth
- REPL N/A
- IMXI N/A
- 52 Week Low
- REPL $2.68
- IMXI $8.58
- 52 Week High
- REPL $17.00
- IMXI $22.37
- Technical
- Relative Strength Index (RSI)
- REPL 75.32
- IMXI 60.36
- Support Level
- REPL $7.69
- IMXI $14.71
- Resistance Level
- REPL $10.85
- IMXI $14.89
- Average True Range (ATR)
- REPL 0.67
- IMXI 0.11
- MACD
- REPL 0.48
- IMXI -0.01
- Stochastic Oscillator
- REPL 88.10
- IMXI 50.00
About REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.
About IMXI International Money Express Inc.
International Money Express Inc is a processor of money transfer services in the USA to the Latin America and the Caribbean (LAC) corridor. The company offers wire transfer, money order, Foreign exchange, and cash checking services, while the majority of the revenue is derived from wire transfer and money order fees. The firm's business is organized around one reportable segment that provides money remittance services between the U.S. and Canada to Mexico, Guatemala, and other countries in Latin America, Africa, and Asia.